28
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      An investigation of antifungal stewardship programmes in England

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose. We sought to explore the current status of antifungal stewardship (AFS) initiatives across National Health Service (NHS) Trusts within England, the challenges and barriers, as well as ways to improve current AFS programmes. Methodology. An electronic survey was sent to all 155 acute NHS Trusts in England. A total of 47 Trusts, corresponding to 30% of English acute Trusts, responded to the the survey; 46 Trusts (98%) had an antimicrobial stewardship (AMS) programme but only 5 (11%) had a dedicated AFS programme. Overall, 20 (43%) Trusts said they included AFS as part of their AMS programmes. From those conducting AFS programmes, 7 (28%) have an AFS/management team, 16 (64%) monitor and report on antifungal usage, 5 (20%) have dedicated AFS ward rounds and 12 (48%) are directly involved in the management of invasive fungal infections. Results/Key findings. Altogether, 13 acute Trusts (52%) started their AFS programme to manage costs, whilst 12 (48%) commenced the programme due to clinical need; 27 (73%) declared that they would increase their AFS initiatives if they could. Of those without an AFS programme, 14 (67%) responded that this was due to lack of resources/staff time. Overall, 12 Trusts (57%) responded that the availability of rapid diagnostics and clinical support would enable them to conduct AFS activities. Conclusion. Although a minority of Trusts conduct dedicated AFS programmes, nearly half include AFS as part of routine AMS activities. Cost issues are the main driver for AFS, followed by clinical need. The availability of rapid diagnostics and clinical support could help increase AFS initiatives.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          A guide for the design and conduct of self-administered surveys of clinicians.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            First hospital outbreak of the globally emerging Candida auris in a European hospital

            Background Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016. This is the first report of C. auris in Europe and the largest outbreak so far. We describe the identification, investigation and implementation of control measures. Methods Data on C. auris case demographics, environmental screening, implementation of infection prevention/control measures, and antifungal susceptibility of patient isolates were prospectively recorded then analysed retrospectively. Speciation of C. auris was performed by MALDI-TOF and typing of outbreak isolates performed by amplified fragment length polymorphism (AFLP). Results This report describes an ongoing outbreak of 50 C. auris cases over the first 16 month (April 2015 to July 2016) within a single Hospital Trust in London. A total of 44 % (n = 22/50) patients developed possible or proven C. auris infection with a candidaemia rate of 18 % (n = 9/50). Environmental sampling showed persistent presence of the yeast around bed space areas. Implementation of strict infection and prevention control measures included: isolation of cases and their contacts, wearing of personal protective clothing by health care workers, screening of patients on affected wards, skin decontamination with chlorhexidine, environmental cleaning with chorine based reagents and hydrogen peroxide vapour. Genotyping with AFLP demonstrated that C. auris isolates from the same geographic region clustered. Conclusion This ongoing outbreak with genotypically closely related C. auris highlights the importance of appropriate species identification and rapid detection of cases in order to contain hospital acquired transmission.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.

              The burden of human disease related to medically important fungal pathogens is substantial. An improved understanding of antifungal pharmacology and antifungal pharmacokinetics-pharmacodynamics has resulted in therapeutic drug monitoring (TDM) becoming a valuable adjunct to the routine administration of some antifungal agents. TDM may increase the probability of a successful outcome, prevent drug-related toxicity and potentially prevent the emergence of antifungal drug resistance. Much of the evidence that supports TDM is circumstantial. This document reviews the available literature and provides a series of recommendations for TDM of antifungal agents.
                Bookmark

                Author and article information

                Journal
                Journal of Medical Microbiology
                Microbiology Society
                0022-2615
                1473-5644
                November 01 2017
                November 01 2017
                : 66
                : 11
                : 1581-1589
                Affiliations
                [1 ] 1​Pharmacy Department, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital Biomedical Campus, Hills Road, Cambridge CB2 0QQ, UK
                [2 ] 2​Antimicrobial Resistance Programme, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK
                [3 ] 3​National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK
                [4 ] 4​Bart’s Health NHS Trust and Blizard Institute, Queen Mary University of London, London, UK
                [5 ] 5​National Infection Service, Public Health England, Public Health Laboratory London, London, UK
                [6 ] 6​Royal Brompton Hospital & Harefield Hospitals NHS FT, Sydney Street, London SW3 6NP, UK
                [7 ] 7​Healthcare Associated Infection and Antimicrobial Resistance Department, National Infection Service, Public Health England, 61 Colindale Avenue, London, UK
                [8 ] 8​Pharmacy Department, Darent Valley Hospital, Dartford and Gravesham NHS Trust, Darenth Wood Road, Dartford, Kent DA2 8DA, UK
                [9 ] 9​Pharmacy Department, Leeds Teaching Hospitals NHS Trust, Leeds, UK
                [10 ] 10​Public Health England South West Laboratory, Myrtle Road, Kingsdown, Bristol BS2 8EL, UK
                [11 ] 11​National Infection Service, Public Health England, Microbiology Laboratory, Addenbrook's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
                Article
                10.1099/jmm.0.000612
                29068278
                49db4d77-54df-4a6b-9a2b-6c188e3bed4f
                © 2017
                History

                Social policy & Welfare,Medicine,Biochemistry,Ecology,Environmental studies,Life sciences

                Comments

                Comment on this article

                scite_

                Similar content258

                Cited by13

                Most referenced authors275